Evidence map›Paper›PMID 29892660›Full record

ArticleJAAD case reports2018

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure.

Warren H Chan, Daniel J Lewis, Esther J Kim, Phyu P Aung, Madeleine Duvic

Open access · goldAbstract readCase Reports
In one paragraph

Article in JAAD case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Eosinophilic fasciitis: unraveling the clinical tapestry of a rare case and review of literature.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Warren H ChanSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Daniel J LewisSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Esther J KimSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Phyu P AungDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Madeleine DuvicDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalized morphea is associated with epoxy resin vapors and is characterized by the development of lesions shortly after exposure. Morphea presenting along with eosinophilic fasciitis (EF), or morphea/EF overlap, is rare and an indicator of poor prognosis and resistance to treatment. Here we present a case of generalized morphea/EF overlap linked to epoxy exposure. Our patient received multiple therapies-ultraviolet A1 phototherapy, prednisone, methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, cyclosporine, and rituximab-none of which led to a significant response. The refractory nature of this disease warrants vigilance in its association with epoxy exposure.

Indexed as

azathioprineBAMM, Bis(4-amino-3-methylcyclohexyl)methaneEF, eosinophilic fasciitisEGPA, eosinophilic granulomatosis with polyangiitiseosinophilic fasciitisepoxygeneralized morpheaHES, hypereosinophilic syndromephototherapyultraviolet A1UVA1, ultraviolet A1

Identifiers

PMID29892660
PMCPMC5993554
OpenAlexW2787571876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.